Pharming Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	15.84	12.85	-8.49	-12.01	14.99	23.08
Depreciation & Amortization	12.09	11.22	16.07	15.93	13.19	19.61
Stock-Based Compensation	14.29	13.77	11.25	9.25	6.39	9.06
Other Adjustments	1.12	9.02	-0.17	-15.73	-10.57	-8.99
Change in Receivables	-4.39	-3.36	-6.78	-18.54	2.36	5.92
Changes in Inventories	-	-1.29	-0.5	-14.43	-15.02	-6.15
Changes in Accounts Payable	-0.06	14.13	-2.77	16.23	11.99	-5.19
Changes in Income Taxes Payable	-6.68	-4.6	-15.58	-0.66	-1.24	-
Changes in Other Operating Activities	7.42	2.97	5.18	2.67	0.36	0.52
Operating Cash Flow	35.03	54.71	-1.8	-17.3	22.46	37.84
Operating Cash Flow Growth	12.82%	-	-	-	-40.65%	-54.75%
Capital Expenditures	-0.66	-0.75	-0.79	-1.44	-1.38	-10.74
Purchases of Intangible Assets	-	-0.01	-0.01	-0.03	-0.6	-5.98
Proceeds from Sale of Intangible Assets	-	-	-	21.28	-	-
Purchases of Investments	-102.96	-0.74	-284.31	-382.01	-	-4.59
Proceeds from Sale of Investments	18.16	85.23	316.73	232.81	7.3	-
Cash Acquisitions	-	-57.48	-	-	-	-
Investing Cash Flow	-85.24	26.25	31.62	-129.39	5.32	-21.31
Long-Term Debt Issued	-	-	104.54	-	-	-
Long-Term Debt Repaid	-	-	-134.92	-	-	-
Net Long-Term Debt Issued (Repaid)	-	-	-30.39	-	-	-
Issuance of Common Stock	18.38	19.81	5.58	8.13	2.28	4.72
Net Common Stock Issued (Repurchased)	18.38	19.81	5.58	8.13	2.28	4.72
Other Financing Activities	-21.69	-18.32	-9.61	-9.17	-7.26	-32.67
Financing Cash Flow	-0.7	1.5	-34.41	-1.04	-4.98	-27.95
Foreign Exchange Rate Adjustments	-0.7	7.91	-2.21	2.13	-7.38	-1.83
Net Cash Flow	-50.91	82.45	-4.59	-147.73	22.8	-11.41
Free Cash Flow	34.37	53.96	-2.59	-18.74	21.08	27.1
Free Cash Flow Growth	14.02%	-	-	-	-22.21%	-65.68%
FCF Margin	12.44%	14.35%	-0.87%	-7.64%	10.25%	13.63%
Free Cash Flow Per Share	0.46	0.72	-0.03	-0.26	0.30	0.39
Levered Free Cash Flow	21.29	24.53	-40.62	7.75	21.59	14.04
Unlevered Free Cash Flow	34.79	68.26	-3.61	12.25	27.74	15.77

SEC Filings: 10-K · 10-Q